Table 1.
Demographics of this influenza vaccination SLE patient cohort.
| All Individuals (n = 72) |
Low Responders (n = 36) |
High Responders (n= 36) |
|
|---|---|---|---|
| Average Age (SD)a | 43 (14) | 43 (13) | 43 (15) |
| African Americanb | 44% | 31% | 58%e |
| European American | 49% | 61% | 36% |
| Hispanic and Otherc | 7% | 8% | 6% |
| Female Sex | 92% | 97% | 86% |
| Median Age at Diagnosis (SD) | 31 (14) | 29 (15) | 33 (14) |
| Average number of ACR criteria (SD) | 5.8 (1.6) | 6.2 (1.4) | 5.5 (1.7) |
| Median Baseline SLEDAI (SD)d | 6.0 (3.8) | 6.0 (4.1) | 5.0(3.4)f |
| Steroid Treatment | 58% | 53% | 64% |
| Anti-Malarial Treatment | 69% | 69% | 69% |
| Combination Steroid and Anti-Malarial | 51% | 50% | 53% |
a
SD = standard deviation
b
Race was self defined
c
Other designation includes individuals that self identified with more than one race (n = 1)
d
Baseline refers to the day of vaccination
e
p = 0.028, by exact Chi-square test
f
p = 0.053, by Wilcoxon two-sample test